AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma

被引:19
作者
Fulcher, Cory D. [1 ]
Haigentz, Missak, Jr. [2 ,3 ,4 ]
Ow, Thomas J. [5 ,6 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bronx, NY 10467 USA
[4] Atlantic Hlth Syst, Dept Med Oncol, Morristown Med Ctr, Morristown, NJ USA
[5] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 3400 Bainbridge Ave,3rd Floor,MAP Bldg, Bronx, NY 10467 USA
[6] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, 3400 Bainbridge Ave,3rd Floor,MAP Bldg, Bronx, NY 10467 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2018年 / 40卷 / 04期
基金
美国国家卫生研究院;
关键词
advanced head and neck cancer; guidelines as topic; head and neck cancer; management; National Comprehensive Cancer Network; PHASE-III TRIAL; CISPLATIN PLUS FLUOROURACIL; MODULATED RADIATION-THERAPY; COOPERATIVE-ONCOLOGY-GROUP; ADVANCED LARYNGEAL-CANCER; PLATINUM-BASED THERAPY; ROUTINE FOLLOW-UP; RANDOMIZED-TRIAL; INDUCTION CHEMOTHERAPY; SALVAGE SURGERY;
D O I
10.1002/hed.25025
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
This article is a continuation of the Do You Know Your Guidelines series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)-negative oropharyngeal cancer where applicable, as HPV-positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate Do you know your guidelines? installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.
引用
收藏
页码:676 / 686
页数:11
相关论文
共 115 条
[1]   Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [J].
Adelstein, DJ ;
Li, Y ;
Adams, GL ;
Wagner, H ;
Kish, JA ;
Ensley, JF ;
Schuller, DE ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :92-98
[2]  
ALSARRAF M, 1987, CANCER TREAT REP, V71, P723
[3]   Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24 [J].
AlSarraf, M ;
Pajak, TF ;
Byhardt, RW ;
Beitler, JJ ;
Salter, MM ;
Cooper, JS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :777-782
[4]  
Amin M.B., 2017, AJCC Cancer Staging Manual, V8th, P123
[5]   Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 [J].
Ang, K. Kian ;
Zhang, Qiang ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Sherman, Eric J. ;
Weber, Randal S. ;
Galvin, James M. ;
Bonner, James A. ;
Harris, Jonathan ;
El-Naggar, Adel K. ;
Gillison, Maura L. ;
Jordan, Richard C. ;
Konski, Andre A. ;
Thorstad, Wade L. ;
Trotti, Andy ;
Beitler, Jonathan J. ;
Garden, Adam S. ;
Spanos, William J. ;
Yom, Sue S. ;
Axelrod, Rita S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2940-+
[6]  
Ang KK, 2002, CANCER RES, V62, P7350
[7]  
[Anonymous], 2016, NIV SCCHN
[8]  
[Anonymous], 2017, HEAD NECK CANC VERS
[9]  
[Anonymous], 2016, MED CALC CARB
[10]  
[Anonymous], ANN ONCOL S6